SCHEMBL6359832

SCHEMBL6359832

COc1ccc(Br)c(C(=O)Nc2ccc(Br)cc2C(=O)O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.57
PKM P14618 1/20 0.53
AKR1C2 P52895 4/20 0.52
AKR1C1 Q04828 3/20 0.52
KCNK2 O95069 1/20 0.52
CA2 P00918 1/20 0.52
AKR1C3 P42330 2/20 0.51
AKR1C4 P17516 1/20 0.51
PLK1 P53350 1/20 0.50
PLK3 Q9H4B4 1/20 0.50
HPGD P15428 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
POLB P06746 2/20 0.48
LMNA P02545 1/20 0.48
ABL1 P00519 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6349388 0.84 MAPT (0.52) MAPTKCNK2CA2PLK1PLK3
SCHEMBL6349859 0.84 MAPT (0.76) MAPTPKMAKR1C2AKR1C1KCNK2
SCHEMBL22720157 0.84 AKR1C3 (0.62) MAPTAKR1C2AKR1C3HPGDMEN1
SCHEMBL6353035 0.83 PKM (0.67) MAPTPKMAKR1C2AKR1C1AKR1C3
SCHEMBL6352170 0.83 LCK (0.59) MAPTAKR1C2AKR1C1KCNK2AKR1C3
SCHEMBL6349807 0.82 AKR1C2 (0.63) MAPTAKR1C2AKR1C1KCNK2AKR1C3
SCHEMBL6352473 0.81 AKR1C2 (0.77) MAPTAKR1C2AKR1C1CA2AKR1C3
SCHEMBL227238 0.79 SMN1; SMN2 (0.59) MAPTPKMAKR1C2CA2AKR1C3
SCHEMBL1308673 0.78 AKR1C2 (0.62) MAPTAKR1C2AKR1C1KCNK2AKR1C3
SCHEMBL6349531 0.76 MEN1 (0.60) MAPTAKR1C2AKR1C1AKR1C3AKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 MAPT 4753/4885PKM 4573/4885AKR1C2 3012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.